Élément architectural d'un édifice, industrie pharmaceutique
CLIENT

GLAXOSMITHKLINE

PROJECT

Research facility for Fluviral vaccine

 

Construction of a research centre on vaccines including an 8,000 sq. ft. animal facility, 20,000 sq. ft. of laboratories and 20,000 sq. ft. of office spaces

MANDATE

Lump-sum construction

 

LOCATION

Laval, Quebec

 

SECTOR

Pharmaceutical and biotechnology

GlaxoSmithKline-252x69
Category
Pharmaceutical